CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potentia ...
Phase 1
San Antonio, Texas, United States and 24 other locations
The aim for this study is to investigate the ability of 64Cu-SAR-bisPSMA PET/CT to detect recurrence of prostate cancer...
Phase 3
San Antonio, Texas, United States of America and 26 other locations
and with darolutamide in men with metastatic castration-resistant prostate cancer. The study aims to assess whether the drug is saf ...
Phase 1
San Antonio, Texas, United States and 12 other locations
Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...
Phase 3
San Antonio, Texas, United States and 42 other locations
1 and Phase 2 study to evaluate the safety and antitumor activity of INV-9956 in adult patients with advanced metastatic Castration Resistant Prostate...
Phase 1, Phase 2
San Antonio, Texas, United States and 16 other locations
purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate...
Phase 1
San Antonio, Texas, United States and 7 other locations
The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate...
Phase 2
San Antonio, Texas, United States and 22 other locations
radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stim...
Phase 3
San Antonio, Texas, United States and 72 other locations
A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...
Phase 1, Phase 2
San Antonio, Texas, United States and 22 other locations
Prostate cancer has the second highest incidence rate and is the fifth leading cause of cancer-related deaths among men wo ...
Phase 1
San Antonio, Texas, United States and 25 other locations
Clinical trials
Research sites
Resources
Legal